Standard Balloon Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update
Standard Balloon Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update
Summary Medical Devices sector report, “Standard Balloon Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Standard Balloon Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Standard Balloon Catheters are coronary catheters equipped with a balloon capable of expanding.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope – Extensive coverage of the Standard Balloon Catheters under development – The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities – The report reviews the major players involved in the development of Standard Balloon Catheters and list all their pipeline projects – The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage – The report provides key clinical trial data of ongoing trials specific to pipeline products – Recent developments in the segment / industry
Reasons to Buy The report enables you to - – Formulate significant competitor information, analysis, and insights to improve R&D strategies – Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage – Identify and understand important and diverse types of Standard Balloon Catheters under development – Develop market-entry and market expansion strategies – Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline – In-depth analysis of the product’s current stage of development, territory and estimated launch date
Our reports have been used by over 10K customers, including:
Report Scope: This report aims to provide a comprehensive study of the global market for stents, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding...
The Coronary Stent Market was Valued at USD 6,671.90 million in 2021, and it is expected to reach USD 8,358.38 million by 2027, registering a CAGR of 3.97 % during the forecast period. The COVID-19 pandemic has had ramifications for ways of working of surgical procedures due to the high rate of infection and lockdown restrictions; a...
“Coronary Stents–Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Coronary Stents pipeline landscape. Owing to the rise in the prevalence of coronary artery diseases (CAD), the coronary stents market is witnessing remarkable growth. Significant players are focusing on expanding...
The global fractional flow reserve market is expected to grow at a CAGR of 12% during 2022-2027 The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography. The demand for FFR is increasing due to its increasing applications in improving patient outcomes, reducing...
200 pages •
By The Business Research Company
• May 2022
Major players in the cardiac assist devices and equipment market are Abbot Laboratories, Berlin Heart GmbH, Abiomed Inc., Bivacor Pvt Ltd., Calon Cardio - Technology Ltd., Cardiobridge GmbH, Balton Sp. Z O.O, Cardiac Assist Inc., Braile Biomedica Ltd., and circulate Inc. The global cardiac assist devices and equipment market is expected...
250 pages •
By The Business Research Company
• May 2022
Major companies in the cardiovascular devices market include Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Inc., Johnson & Johnson, Terumo Corporation, Getinge Group, Teleflex Inc., and Becton Dickinson. The global cardiovascular devices market is expected to grow from $53.44...
The cardiovascular devices market is expected to grow from US$ 48,106.47 million in 2021 to US$ 76,526.68 million in 2028; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028. The growth of the market is due to the increasing prevalence of cardiovascular diseases and the rising number of product launches & approvals. However, the high...
120 pages •
By Infiniti Research Limited
• Mar 2022
Global Heart Valve Repair And Replacement Devices Market 2022-2026 The analyst has been monitoring the heart valve repair and replacement devices market and it is poised to grow by $ 3.01 bn during 2022-2026 progressing at a CAGR of 8.1% during the forecast period. Our report on the heart valve repair and replacement devices...
The global cardiovascular devices market reached a value of US$ 51.34 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 77.92 Billion by 2027 exhibiting a CAGR of 6.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the...
Cardiovascular Devices
World
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.